Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 13/20 | 0.50 |
| ▸ | NPY1R | P25929 | 7/20 | 0.50 |
| ▸ | NPY2R | P49146 | 5/20 | 0.50 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.50 |
| ▸ | CTSD | P07339 | 2/20 | 0.43 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.40 |
| ▸ | CTSB | P07858 | 1/20 | 0.40 |
| ▸ | CTSK | P43235 | 1/20 | 0.40 |
| ▸ | REN | P00797 | 1/20 | 0.40 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.40 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.40 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29973033 | 0.97 | NPY4R (0.50) | NPY4RNPY1RNPY2RNPY5RKISS1R | |
| SCHEMBL29770304 | 0.93 | NPY4R (0.51) | NPY4RNPY1RNPY2RNPY5RCTSD | |
| SCHEMBL30353300 | 0.91 | NPY4R (0.44) | NPY4RNPY1RNPY2RNPY5RCTSD | |
| SCHEMBL29379956 | 0.88 | NPY4R (0.52) | NPY4RNPY1RNPY2RNPY5RCTSD | |
| SCHEMBL31084112 | 0.87 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5RRXFP1 | |
| SCHEMBL29458807 | 0.85 | BACE1 (0.48) | NPY4RNPY1RNPY2RNPY5RCTSD | |
| SCHEMBL30812336 | 0.85 | NPY4R (0.46) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30311080 | 0.85 | ENPEP (0.47) | — | |
| SCHEMBL30945402 | 0.85 | NPY4R (0.51) | NPY4RNPY1RNPY2RNPY5RCTSD | |
| SCHEMBL29799968 | 0.85 | NPY4R (0.51) | NPY4RNPY1RNPY2RNPY5RCTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3233102-B1 | USE OF AN ANTIMICROBIAL PEPTIDE TO INDUCE CELL DEATH IN BREAST CANCER | BOLKENT SEHNAZ (TR) | 2024-03-06 | — | — | EP | disclosed |